Endoluminal Stent-Graft Repair of Aortobronchial Fistulas: Bridging or Definitive Long-Term Solution?

Böckler, Dittmar; Schumacher, H.; Schwarzbach, Matthias; Ockert, S.; Rotert, Harald; Allenberg, Jens-Rainer

doi:10.1177/152660280401100105

Cited by 33 publications

(34 citation statements)

References 33 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The procedures for surgical cutdown and access have been previously published [16,17]. Digital subtraction angiography was performed with the breath-hold technique followed by injection of 20 mL of nonionic contrast medium (Iomeron 400 [iomeprol], AltanaPharma, Konstanz, Germany) administered by automated injection (Injector System Mark V ProVis KMP910G, Medrad, Indianola, PA, USA; Injektron 82 HP, Medtron, Saarbrücken, Germany).…”

Section: Surgical Approach and Techniquementioning

confidence: 99%

The Endurant Stent Graft System: 15-month follow-up report in patients with challenging abdominal aortic anatomies

Hyhlik‐Dürr

Weber

Kotelis

et al. 2011

Langenbecks Arch Surg

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Surgical Approach and Techniquementioning

confidence: 99%

The Endurant Stent Graft System: 15-month follow-up report in patients with challenging abdominal aortic anatomies

Hyhlik‐Dürr

Weber

Kotelis

et al. 2011

Langenbecks Arch Surg

Self Cite

View full text Add to dashboard Cite

show abstract

“…Consequently, TEVAR can be seen as safe, reliable, and durable treatment of ABF without the actual need for secondary conversion (removal of stent graft). 21 In our experience, even for recurrent hemoptysis (because of material fatigue), redo TEVAR seems justified. For AEF, TEVAR also provides a straightforward method to achieve bleeding control by aortic sealing.…”

Section: Discussionmentioning

confidence: 68%

Strategies for Endovascular Aortic Repair in Aortobronchial and Aortoesophageal Fistulas

Dorweiler

Weigang

Duenschede

et al. 2013

Thorac cardiovasc Surg

View full text Add to dashboard Cite

Objective To report our experience of thoracic endovascular aortic repair (TEVAR) for acute bleeding originating from the thoracic aorta in patients with aortobronchial fistula (ABF) or aortoesophageal fistula (AEF). Patients and Methods A total of nine patients (three woman) were treated from September 1995 to March 2012 by TEVAR for ABF (n ¼ 5) and AEF (n ¼ 4). The implants (N ¼ 14) were introduced with fluoroscopic guidance via the aorta (n ¼ 1), the iliac (n ¼ 2), or femoral (n ¼ 11) artery, respectively. Results All aortic lesions could be sealed successfully. Perioperative morbidity was 0% in the ABF group and 50% (2 of 4) in the AEF group and no procedure-related morbidity was noted except one patient who received aortofemoral reconstruction because of iliac occlusive disease. After an overall mean follow-up of 56 months, three patients of the ABF group are alive and well and two patients died of nonrelated cause. Of the AEF group, one patient is alive after 22 months, and one died from metastasized esophageal cancer after 7 months. Conclusion TEVAR is a safe and reliable procedure in the management of ABF. For AEF, TEVAR provides a successful first-line treatment to seal the fistula and control bleeding. However, prognosis is limited by the esophageal lesion and by ongoing mediastinitis/ sepsis.

show abstract

“…However, strong suspicion is required in order to diagnose aortic fistulas to nearby structures (3,9,10).…”

Section: -5mentioning

confidence: 99%

Death due to Aortobronchial Fistula Related Massive Hemoptysis a Case Report

Özsoy¹,

Alkan²,

Pehlivan³

et al. 2016

Bull Leg Med

View full text Add to dashboard Cite

Aortobronchial fistulas are relatively rare but usually fatal if not treated since they might cause massive hemoptysis. Here we present a case of death of a 17-year-old male due to massive hemoptysis secondary to aortobronchial fistula. The deceased was firstly admitted to an emergency department with dyspnea, tachypnea, tachycardia, resistant metabolic acidosis, confusion, and somnolence. He was diagnosed with “diabetic ketoacidosis” following examinations; however, detailed radiological and clinical investigations revealed community-acquired infection findings and medical treatment was started accordingly. He was discharged after 15 days of hospitalization; however, he died unexpectedly 12 days after discharge.At autopsy a 4-cm aortobronchial fistula was found between the thoracic aortic wall and the left main bronchus. Histopathological examination of fistula showed diffuse and intense necro-inflammatory reaction and inflammatory response with polymorphonuclear leukocytes and necrosis. Death was attributed to massive hemoptysis and blood aspiration due to aortobronchial fistula.A feedback system, towards healthcare centers, based on autopsy findings and exact cause and mechanisms of death will contribute improvement of diagnosis and treatment approach.Keywords: Aortopulmonary fistula; Respiratory Tract Fistula; Bronchial Fistula; Vascular Fistula; Hemoptysis; Cannabinoids; Autopsy.

show abstract

Endoluminal Stent-Graft Repair of Aortobronchial Fistulas: Bridging or Definitive Long-Term Solution?

Abstract: Endoluminal stent-grafting of ABF is feasible and the preferred method of treatment. Secondary conversion due to endograft infection is not absolutely mandatory, but close surveillance is necessary.

Cited by 33 publications

References 33 publications

The Endurant Stent Graft System: 15-month follow-up report in patients with challenging abdominal aortic anatomies

The Endurant Stent Graft System: 15-month follow-up report in patients with challenging abdominal aortic anatomies

Strategies for Endovascular Aortic Repair in Aortobronchial and Aortoesophageal Fistulas

Death due to Aortobronchial Fistula Related Massive Hemoptysis a Case Report

Contact Info

Product

Resources

About